o2h Ventures Therapeutics Fund

Venture Capital

Portfolio

companies

By category

BioTech£14.0M

By location

Cambridge£14.0M

Portfolio companies

Metrion Biosciences

Metrion Biosciences provides specialist ion channel screening and drug discovery services.

Recent investments

Seed1 April 2019

£14.0M

Metrion Biosciences raises £14m from o2h Ventures to expand screening capabilities

BioTech

The funding round was led by o2h Ventures Therapeutics Fund and supported by existing backers.

"We are pleased to welcome both o2h Ventures Therapeutics Fund as a new shareholder and Sunil Shah, Managing Partner of o2h Ventures Ltd as an observer on the Metrion board."

— Keith McCullagh, Chairman

Metrion Biosciences—Cambridge, UKFollow

o2h Ventures Therapeutics Fund